RVNCRevance Therapeutics, Inc.

Nasdaq revance.com


$ 3.32 $ -0.97 (-22.61 %)    

Friday, 10-May-2024 15:59:54 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 3.32
$ 3.87
$ 0.00 x 0
$ 0.00 x 0
$ 3.00 - $ 3.90
$ 3.00 - $ 36.70
8,076,288
na
305.17M
$ 1.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-04-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
23 11-02-2018 09-30-2018 10-Q
24 08-03-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 03-02-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 08-04-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-04-2016 09-30-2016 10-Q
32 08-05-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-04-2016 12-31-2015 10-K
35 11-10-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-04-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-13-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-reiterates-overweight-on-revance-therapeutics-lowers-price-target-to-11

Piper Sandler analyst David Amsellem reiterates Revance Therapeutics (NASDAQ:RVNC) with a Overweight and lowers the price ta...

 mizuho-maintains-neutral-on-revance-therapeutics-lowers-price-target-to-8

Mizuho analyst Vamil Divan maintains Revance Therapeutics (NASDAQ:RVNC) with a Neutral and lowers the price target from $9 t...

 needham-maintains-buy-on-revance-therapeutics-lowers-price-target-to-12

Needham analyst Serge Belanger maintains Revance Therapeutics (NASDAQ:RVNC) with a Buy and lowers the price target from $18 ...

 revance-continues-to-expect-2024-total-net-product-revenue-which-includes-sales-of-daxxify-and-rha-collection-to-be-at-least-280m

With cash, cash equivalents, and short-term investments of $277.1 million as of March 31, 2024, and anticipated revenues and ex...

 revance-therapeutics-q1-2024-gaap-eps-054-beats-063-estimate-sales-51936m-miss-56634m-estimate

Revance Therapeutics (NASDAQ:RVNC) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of ...

 revance-to-present-new-daxxify-data-at-the-american-academy-of-neurology-2024-annual-meeting

– Two presentations highlighting data on DAXXIFY® for the treatment of cervical dystonia, including a new analysis from ASPEN t...

 blackberry-nurix-therapeutics-tesla-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) ...

 gds-holdings-coinbase-and-other-big-stocks-moving-higher-in-mondays-pre-market-session

U.S. stock futures were lower this morning, with the Dow futures falling by around 100 points on Monday. Shares of GDS Holdin...

 why-bitdeer-technologies-shares-are-trading-higher-by-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported prelimina...

 tesla-spirit-airlines-new-york-community-bancorp-and-other-big-stocks-moving-lower-on-monday

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.

 revance-announces-pricing-of-100m-public-offering-of-16m-shares-of-common-stock-at-a-price-of-625share

Revance Therapeutics, Inc. (NASDAQ:RVNC) ("Revance" or the "Company") today announced the pricing of an underwr...

 goldman-sachs-maintains-neutral-on-revance-therapeutics-raises-price-target-to-9

Goldman Sachs analyst Chris Shibutani maintains Revance Therapeutics (NASDAQ:RVNC) with a Neutral and raises the price targe...

 hc-wainwright--co-reiterates-buy-on-revance-therapeutics-maintains-12-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Revance Therapeutics (NASDAQ:RVNC) with a Buy and maintains $12 pric...

 why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

 hormel-foods-reports-upbeat-earnings-joins-pure-storage-okta-papa-johns-international-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION